Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Cessation Clinics

 
Centre de Sevrage du Tabac a L'Hopital Hôtel-Dieu de France
Introduction:
 
The Smoking Cessation Center at Hôtel-Dieu de France has a specialized consultation and support unit dedicated for smoking cessation and composed of a team of nurses, doctors, psychologists and nutritionists. Its objective is to medically support smokers willing to quit through weekly consultations and activities, follow up with hospitalized patients, spread awareness and partake in tobacco prevention campaigns on a national and international level
 
Name Address Technique Duration Cost Phone Email Website
Centre de Sevrage du Tabac
 
Hôtel-Dieu de France – Achrafieh, Beirut
 
Medical evidence based treatment 3- 6 months (more or less) It will depend on each individual case 01/604000 ext. 8081- 8082
 
sevragetabac@hdf.usj.edu.lb
 
https://www.hdf.usj.edu.lb/cst
 
 
Stop Smoking Lebanon by Maguy Nassar
Introduction:

For more than 20 years of experience with smokers or social smokers I advise them to stop or limit their addiction, it's not a dream it's a great technology in one session. 
My name is Maguy Nassar, I do acupuncture by light on ears and face by stimulating 5 energetics points (the will, the gesture,nicotine,stress&bulimia)
One session No side effects, even pregnant woman can benefit from the session. 
Duration: 30 to 45 minutes.
 
Name Address Technique Duration Cost Phone Email Website
Stop Smoking Lebanon Center Jdeideh & Zgharta Laser-acupuncture 30 to 45 minutes - 03/680691 maguynassar@gmail Stopsmokinglebanon.com
 
REALIZE Center
Smoking Cessation Program
 
Introduction:
 
The smoking cessation program includes 10 sessions of counseling and therapy under the supervision of a certified psychotherapist, a dietician and a physician.

Sessions are based on international clinical guidelines that involve motivational sessions, learning behavior modification, nicotine replacement therapy and others.
 
Name Address Technique Duration Cost Phone Email Website
REALIZE Center
 
Jal El Dib
 
Psychotherapy and nicotine replacement therapy around 3 months (depends on each individual) - 70/387738
 
rachellebardawil@gmail.com
 

 
70/926829 realizetherapycenter@gmail.com
 
    5
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AC05 STELARA BioTech Ustekinumab - 45mg 45mg Injectable solution L.L
A10BJ02 SAXENDA BioTech Liraglutide - 6mg/ml 6mg/ml Injectable solution 16,747,035 L.L
J06BD01 SYNAGIS BioTech Palivizumab - 100mg/ml 100mg/ml Injectable solution 57,429,464 L.L
J06BD01 SYNAGIS BioTech Palivizumab - 50mg/0.5ml 50mg/0.5ml Injectable solution 38,316,693 L.L
A10AE54 SULIQUA BioTech Insulin glargine - 100IU/ml, Lixisenatide - 50mcg/ml Injectable solution 11,286,573 L.L
A10AE54 SULIQUA BioTech Insulin glargine - 100IU/ml, Lixisenatide - 33mcg/ml Injectable solution 7,975,793 L.L
L04AB06 SIMPONI BioTech Golimumab - 50mg/0.5ml 50mg/0.5ml Injectable solution 75,598,955 L.L
L04AB06 SIMPONI BioTech Golimumab - 100mg/1ml 100mg/1ml Injectable solution 75,598,955 L.L
L04AC02 SIMULECT BioTech Basiliximab - 20mg 20mg Injectable powder + solvent 137,661,787 L.L
L04AC05 STELARA BioTech Ustekinumab - 45mg 45mg Injectable solution 157,788,141 L.L
L04AC05 STELARA BioTech Ustekinumab - 45mg 45mg Injectable solution 157,788,141 L.L
L04AC05 STELARA BioTech Ustekinumab - 90mg 90mg Injectable solution 157,788,141 L.L
L04AC05 STELARA BioTech Ustekinumab - 90mg 90mg Injectable solution L.L
L04AC05 STELARA BioTech Ustekinumab - 90mg 90mg Injectable solution 157,788,141 L.L
L04AC05 STELARA BioTech Ustekinumab - 130mg 130mg Injectable concentrate for solution 235,593,517 L.L
L01FG01 STIVANT BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable concentrate for solution 27,359,527 L.L
L04AC18 SKYRIZI BioTech Risankizumab - 150mg 150mg Injectable solution 194,911,251 L.L
L01FG01 STIVANT BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 14,719,570 L.L
L04AC05 STELARA BioTech Ustekinumab - 130mg 130mg Injectable concentrate for solution L.L
L04AX04 SOTIRA G Lenalidomide - 10mg 10mg Capsule 72,248,183 L.L
M04AA03 STABURIC G Febuxostat - 120mg 120mg Tablet, film coated 1,420,889 L.L
B05BC01 SERUFLEX MANNITOL 20% INJECTION, USP G Mannitol - 20g/100ml 20g/100ml Injectable solution 402,213 L.L
B05BC01 SOLUFLEX MANNITOL 20% INJECTION, USP G Mannitol - 20g/100ml 20g/100ml Injectable solution 603,320 L.L
J05AG03 STOVIRENZ G Efavirenz - 600mg 600mg Tablet, film coated 6,857,456 L.L
M04AA03 STABURIC G Febuxostat - 80mg 80mg Tablet, film coated 1,355,489 L.L
M04AA03 STABURIC G Febuxostat - 40mg 40mg Tablet, film coated 1,081,345 L.L
A06AD61 SOFLAX G Lactose - less than 6g/100ml, Galactose - less than 11g/100ml, Lactulose - 67g/100ml Solution 258,018 L.L
L04AX04 SOTIRA G Lenalidomide - 15mg 15mg Capsule 76,208,289 L.L
R05C SULDEX G Caffein anyhdrous - 0.216g, Antipyrine - 0.972g, Potassium sulfaguaiacolate - 1.44g Syrup 152,302 L.L
C10AA05 STORVAS G Atorvastatin (calcium) - 10mg 10mg Tablet, film coated 362,837 L.L
    5
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025